13D Filing: Intersouth Partners VI LP and Alimera Sciences Inc (ALIM)

Page 1 of 19

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Intersouth Partners V 0 300,168 0 300,168 300,168 0.5%
Intersouth Affiliates V 0 14,068 0 14,068 14,068 0.02%
Intersouth Associates V 0 314,236 0 314,236 314,236 0.5%
Intersouth Partners VI 0 382,715 0 382,715 382,715 0.6%
Intersouth Associates VI 0 382,715 0 382,715 382,715 0.6%
Intersouth Partners VII 0 212,210 0 212,210 212,210 0.3%
Intersouth Associates, VII 0 212,210 0 212,210 212,210 0.3%
Dennis Dougherty 0 909,161 0 909,161 909,161 1.4%
Mitch Mumma 0 909,161 0 909,161 909,161 1.4%

Page 1 of 19 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Amendment No. 1)*

Under the Securities Exchange Act of 1934

ALIMERA
SCIENCES, INC.

(Name of Issuer)

Common Stock, $0.01 Par Value

(Title of Class of Securities)

016259103

(CUSIP Number)

Intersouth Partners

c/o Dennis Dougherty

102
City Hall Plaza, Suite 200

Durham, NC 27701

(919) 493-6640

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 16, 2016

(Date of Event which Requires Filing of this Statement)

If the filing person has
previously filed a statement on Schedule l3G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).

Follow Alimera Sciences Inc (NASDAQ:ALIM)

Page 1 of 19